Fundraising Fox

Expansion Therapeutics

Del Mar, US · Founded 2016 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

Expansion Therapeutics was founded in 2016 by Matthew Disney.

MD
Matthew DisneyFounder
PSPaul Stone
Paul StoneinExecutiveLegal Advisor at 5AM Ventures
YH
Yujiro HataExecutive
KF
Kevin ForrestExecutive

Board

SRScott Rocklage
Scott RocklageinBoard directorFounding Partner at 5AM Ventures
JHJason Hafler
Jason HaflerinBoard directorManaging Director at Sanofi Ventures

Investors · 4

5AM VenturesBoston · $100K – $4M
Kleiner PerkinsreportedMenlo Park · $500K – $15M
Novartis Venture FundreportedBasel · $5M – $25M
Sanofi Venturesreported · 2 sourcesCambridge · $5Mvia Jason P. Hafler · board

Reported raises · per SEC filings

Form D private placements

$78.3M disclosed across 3 rounds · 2016–2021

▶$48MraisedOct 2021 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Renato Skerlj, Ph.D.Executive Officer, Director
  • Laura Tadvalkar, Ph.D.Director
  • Andy Phillips, Ph.D.Director
  • Scott Rocklage, Ph.D.Director
  • Beth Seidenberg, M.D.Director
Offering amount
$80.1M
Amount sold
$48M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.3MraisedJan 2018 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin Forrest, Ph.D.Executive Officer, Director
  • Campbell Murray, M.B.B.S., M.B.A.Director
  • Yujiro Hata, M.B.A.Director
  • Matthew Disney, Ph.D.Director
  • Beth Seidenberg, M.D.Director
  • Scott Rocklage, Ph.D.Director
  • Jason Hafler, Ph.D.Director
Offering amount
$55.3M
Amount sold
$25.3M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJun 2017 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul StoneExecutive Officer
  • Yujiro HataDirector
  • Kevin ForrestExecutive Officer, Director
  • Scott RocklageExecutive Officer, Director
  • Matthew DisneyDirector
  • Jason HaflerDirector
Offering amount
$5M
Amount sold
$5M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Sell or Invest in Expansion Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · Jun 2025Expansion Therapeutics Widens Funding by $80 Million for RNA-Linked Research - BioSpacebiospace.com · Sep 2021Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseasesbusinesswire.com · Sep 2021Expansion Therapeutics Raises $55.3 Million In Series A Financing | Reutersreuters.com · Jan 2018

Frequently asked questions

Who founded Expansion Therapeutics?
Expansion Therapeutics was founded by Matthew Disney in 2016.
Who are Expansion Therapeutics's investors?
Expansion Therapeutics's investors include 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, Sanofi Ventures.
How much funding has Expansion Therapeutics raised?
Expansion Therapeutics has disclosed $78.3M raised across 3 rounds.
Where is Expansion Therapeutics headquartered?
Expansion Therapeutics is headquartered in Del Mar, US.